Trends in Drug Discovery in Diabetes and Obesity
Edited by Lars Linderoth Edited by Søren Østergaard Series edited by János Fischer Series edited by Christian Klein Series edited by Wayne E. Childers Series edited by David P. Rotella
Hardback (Forthcoming)
(September 2026)
ISBN: 9783527353309
6.69 x 9.65 inches
Price: $187.00
On back order
Trends and challenges in one of the key areas of contemporary drug development – presented by industry professionals from leading pharmaceutical companies.
Trends and challenges in one of the key areas of contemporary drug development – presented by industry professionals from leading pharmaceutical companies.
Tabel of contents
Preface
Chapter 1. The role of gut peptides in the regulation of body weight.
Chapter 2. Agonists and antagonists of the human GIP receptor
Chapter 3. Amylin ? biological aspects
Chapter 4. Peptide-based GLP-1 receptor agonists for the treatment of type 2 diabetes and obesity
Chapter 5. Oral agents used to treat type 2 diabetes and obesity
Chapter 6. Trends in the field of insulin drug design
Chapter 7. Neuropeptide Y receptor ligands and opportunities within diabetes and obesity
Chapter 8 PrRP-GPR10 signalling and metabolism
Chapter 9. The becoming of dasiglucagon
- Edited by Lars Linderoth
- Edited by Søren Østergaard
- Series edited by János Fischer
- Series edited by Christian Klein
- Series edited by Wayne E. Childers
- Series edited by David P. Rotella
Similar Books
Recycling and Regeneration of Spent Lithium-Ion Batteries
Technologies, Applications, and Sustainable Futures
Medicinal Chemistry of Plant-Derived Natural Products
A Chemical Exploration of Plants as a Source of Modern Drugs
Ernst Haeckel: Ausgewählte Briefwechsel. Historisch-kritische Ausgabe. Bd. 8
Briefwechsel mit Carl Gegenbaur. Wissenschaftskorrespondenz. Mai 1858 – Juli 1902
